The shortage of generic chemotherapy drugs cisplatin and carboplatin that began in early 2023 did not increase short-term ...

For the second legislative session in a row, Sen. Willie Preston is pushing to ban several chemicals from Illinois food items ...

Q4 2024 Management View CEO Corey Fishman emphasized 2024 as a pivotal year, highlighting the FDA approval of ORLYNVAH, the first and only oral penem in the U.S. for uncomplicated urinary tract ...

Iterum Therapeutics PLC (NASDAQ:ITRM) reported its fourth-quarter 2024 financial results, revealing a narrower-than-expected loss. The company posted an actual EPS of -0.12, beating the forecasted EPS ...